SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

IMMUDYNE INC (IMMD)

IMMD RSS Feed
Add IMMD Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/30/2016 9:27:48 AM - Followers: 48 - Board type: Free - Posts Today: 0


 

IMMUDYNE, INC. (OTCQB: IMMD)
 

Immudyne, Inc. (OTCQB: IMMD) is a science-based wellness & healthcare company. Immudyne manufactures and sells clinically researched, doctor-recommended, yeast beta-1, 3 / 1, 6-D-glucan dietary supplements and topical skin lines.

 

PuraCere: Empower Your Immune Health

Your immune system controls your skin’s health and appearance. From regeneration and protection, to clearing of scars and acne. Activated, topical immune cells heal microscopic wounds, fight against infection, regenerate your skin, and counteract the damage from UV-ray exposure, environmental toxins, and the aging process.

PURACERETM is a naturally powerful immune support supplement. Through a proprietary process, PURACERE is extracted from Saccharomyces cerevisiae producing the purist yeast beta-1, 3 / 1, 6-D-glucan available. Hundreds of clinical studies confirm that yeast beta-1, 3 / 1, 6-D-glucans are powerful immunomodulators.

 

Products: iNR Wellness,  iNR Wellness MD,  iNR Strength,  NAYAD Serum

iNR Wellness MD is a nutritional supplement that naturally empowers your immune system with PURACERE™, IP-6, and a vitamin C complex. PURACERE is a naturally powerful immune support supplement and clinically proven to provide immune health benefits. This is why iNR Wellness MD is recommended by doctors and medical experts worldwide.

iNR STRENGTH is a nutritional supplement that naturally supports the immune system with PURACERE™ and antioxidants. PURACERE is a naturally powerful immune support supplement and clinically proven to provide immune health benefits. iNR Strength also contains the antioxidants riboflavin and thiamine, to help support energy conversion into lean muscle. This is why iNR Strength is recommended by health and wellness experts worldwide.

NAYAD Rejuvenating Serum

NAYAD is an ultrapure, topical beta-1,3/1,6-D-glucan. NAYAD is a naturally derived skincare solution that has been clinically proven to provide powerful anti-aging results. NAYAD stimulates collagen production and natural cell renewal. Scientific studies have shown that NAYAD directly connects with and activates Langerhans cells. Langerhans cells are topical immune cells. When activated, they heal microscopic wounds, fight against infection, regenerate your skin, and counteract the damage from UV-ray exposure, environmental toxins, and the aging process.

 

Management

Anthony G. Bruzzese, MD, Chairman
Mark McLaughlin, President and CEO
Sven Rohmann, MD, PhD, Global Chief Medical Officer
Joseph V. DiTrolio, MD, Chief Medical Officer, US
John Strawn, Esq., Legal


Company Ticker:    IMMD

# Shares Outstanding:    30 MM

No Debt

Average Daily Volume:    38,000

52 week range:    $0.05 – $0.41

S.E.C. Counsel: Kane Kessler 

Auditor: PKF O’Connor Davies

For further information, please contact: Immudyne, Inc.

Mark McLaughlin President & CEO

+1-914-714-8901

MarkMcL@immudyne.com

 

 

 

The Daily View



The Weekly View






 

Moderator's Disclaimer - This board is for (IMMD) discussion purposes only and is in no way a recommendation to buy or sell. Any investment decisions should be based on your own due diligence and decision. You are solely responsible for your choices to buy or sell.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMMD
Current Price
Volume:
Bid Ask Day's Range
SureTrader
IMMD News: ImmuDyne Signs Exclusive License Agreement for Proprietary Dermatologist Backed Hair Loss Product 09/09/2016 08:00:00 AM
IMMD News: Current Report Filing (8-k) 08/15/2016 04:21:03 PM
IMMD News: Quarterly Report (10-q) 08/15/2016 04:19:01 PM
IMMD News: lmmuDyne Announces Q2 2016 Net Sales Up 343%, Adjusted Non-GAAP Net Income 08/15/2016 08:30:00 AM
IMMD News: ImmuDyne Signs Non-Binding Term Sheet for Exclusive Rights to Dermatologist Backed Hair Loss Product 07/12/2016 09:24:45 AM
PostSubject
#2276   It has been quiet for a while in Happy Investor 09/30/16 09:27:47 AM
#2275   Looks like IMMD is on the straight way binnenfuchs 09/20/16 06:25:00 PM
#2274   My favourite line from the last press release: binnenfuchs 09/13/16 09:38:55 AM
#2273   Thanks Latinachica 08/23/16 11:53:06 AM
#2272   After a closer look at the 10-Q SEC binnenfuchs 08/23/16 11:50:08 AM
#2271   Seems like earnings was very good Latinachica 08/15/16 09:57:52 AM
#2270   Thanks Latinachica 08/08/16 09:07:25 AM
#2269   In 2013-2015 they reported Q2 around August 13th/14th.. binnenfuchs 08/08/16 07:06:56 AM
#2268   When do they report? Latinachica 08/08/16 06:49:46 AM
#2267   Holding IMMD can be painful ;) Though I'm binnenfuchs 08/08/16 06:47:23 AM
#2266   Who even buys this? I hold bags Latinachica 08/05/16 06:49:27 PM
#2265   Nice addition for IMMD ! Hair loss market pmunch 07/12/16 12:58:58 PM
#2264   IMMD is being positioned as a developer and Happy Investor 07/12/16 09:32:38 AM
#2263   news- ImmuDyne Signs Non-Binding Term Sheet for Exclusive mrgoodtrade 07/12/16 09:25:52 AM
#2262   IMMD five mms at .26 or better - mrgoodtrade 06/03/16 10:26:14 AM
#2261   Very Good Addition to Advisory Board and Move, pmunch 06/01/16 05:19:34 PM
#2260   VERY POSITIVE MOVE AND ANNOUNCEMENT that will accelerate Happy Investor 06/01/16 12:29:03 PM
#2259   MT. KISCO, N.Y., Dec. 10, 2015 (GLOBE NEWSWIRE) Happy Investor 05/24/16 09:53:21 AM
#2258   Very good research. I agree with your Happy Investor 05/17/16 03:20:39 PM
#2257   The press release today was definitely needed to binnenfuchs 05/17/16 12:49:36 PM
#2256   Ramping up sales of a relatively new (in Happy Investor 05/17/16 09:11:25 AM
#2255   The acquisition costs were high and have been xrymd 05/17/16 07:36:38 AM
#2254   IMMD released the Q1 report and it pretty binnenfuchs 05/16/16 08:30:31 PM
#2253   Looks like market makers moving it back down Happy Investor 04/22/16 03:33:48 PM
#2252   IMMD .37 1.5 yr weekly chart - mrgoodtrade 04/21/16 12:59:02 PM
#2251   Great chart. A nice P.R., bringing intensified demand Happy Investor 04/19/16 05:50:59 AM
#2250   IMMD .375 3yr chart - closing in on mrgoodtrade 04/18/16 04:24:37 PM
#2249   I agree. But this CEO absolutely sucks Happy Investor 04/15/16 11:58:53 AM
#2248   Times have changed, IMMD looks like they have pmunch 04/15/16 10:14:00 AM
#2247   I was correct. IMMD hit $.395 and Happy Investor 04/13/16 11:17:31 AM
#2246   $.40 may be a challenge. We have Happy Investor 04/11/16 01:59:04 PM
#2245   Beauty !! Should be getting there soon pmunch 04/11/16 12:09:06 PM
#2244   Only 30,000 shares and $12,000 to $.58. Happy Investor 04/11/16 10:07:04 AM
#2243   Be happy... More revenue stream pmunch 04/08/16 02:14:47 PM
#2242   Results? What results? They didn't publish Q1 Happy Investor 04/08/16 02:05:07 PM
#2241   "Could" is speculative and based on a certain Happy Investor 04/08/16 02:03:18 PM
#2240   I take issue with your characterization of my Happy Investor 04/08/16 01:58:01 PM
#2239   $IMMD ImmuDyne Increases its Ownership Interest In Innate $Pistol Pete$ 04/08/16 10:29:04 AM
#2238   nice! from IMMD pr: mrgoodtrade 04/08/16 09:14:48 AM
#2237   Beautiful update on IMMD , major results pmunch 04/08/16 08:42:11 AM
#2236   IMMD Expects Sales of $10M in 2016; Increase stervc 04/08/16 08:36:17 AM
#2235   Sorry, but judging from this and your previous binnenfuchs 04/08/16 06:21:48 AM
#2234   You have a simple view. What if Happy Investor 04/07/16 03:22:28 PM
#2233   Easy.. I call Q1 a success, because of binnenfuchs 04/07/16 10:38:12 AM
#2232   Just 33,000 shares or $12,000 to reach $.50. Happy Investor 04/07/16 10:03:15 AM
#2231   We do not KNOW that Q1 was a Happy Investor 04/07/16 10:00:01 AM
#2230   Well, we already know that Q1 was a binnenfuchs 04/07/16 06:26:30 AM
#2229   Level 2 today....40,000 shares, just $12,000 takes us Happy Investor 04/06/16 02:26:45 PM
#2228   Looking at Level 2, it seems that less Happy Investor 04/04/16 02:34:25 PM
#2227   Any news out on Q1..? - I was binnenfuchs 03/31/16 11:11:15 AM
PostSubject